Related Experiment Video
Updated: Oct 19, 2025
Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
Survival and associated comorbidities in inclusion body myositis
Elie Naddaf1, Shahar Shelly1, Jay Mandrekar2
1Department of Neurology.
Objective:
To evaluate survival and associated comorbidities in inclusion body myositis (IBM) in a population-based, case-control study.
Methods:
We utilized the expanded Rochester Epidemiology Project medical records-linkage system, including 27 counties in Minnesota and Wisconsin, to identify patients with IBM, other inflammatory myopathies (IIM), and age/sex-matched population-controls. We compared the frequency of various comorbidities and survival among groups.
Results:
We identified 50 IBM patients, 65 IIM controls and 294 population controls. Dysphagia was most common in IBM (64%) patients. The frequency of neurodegenerative disorders (dementia/parkinsonism) and solid cancers was not different between groups. Rheumatoid arthritis was the most common rheumatic disease in all groups. A total of 36% of IBM patients had a peripheral neuropathy, 6% had Sjögren's syndrome and 10% had a haematologic malignancy. T-cell large granular lymphocytic leukaemia was only observed in the IBM group. None of the IBM patients had hepatitis B or C, or HIV. IBM patients were 2.7 times more likely to have peripheral neuropathy, 6.2 times more likely to have Sjögren's syndrome and 3.9 times more likely to have a haematologic malignancy than population controls. IBM was associated with increased mortality, with a 10-year survival of 36% from index, compared with 67% in IIM and 59% in population controls. Respiratory failure or pneumonia (44%) was the most common cause of death.
Conclusions:
IBM is associated with lower survival, and higher frequency of peripheral neuropathy, Sjögren's syndrome and haematologic malignancies than the general population. Close monitoring of IBM-related complications is warranted.
Insights
Inclusion body myositis (IBM) patients face significantly lower survival rates and a higher incidence of peripheral neuropathy, Sjögren's syndrome, and hematologic malignancies compared to the general population. Careful monitoring for IBM complications is crucial.
Area of Science:
- Neurology
- Immunology
- Epidemiology
Background:
- Inclusion body myositis (IBM) is a rare, progressive idiopathic inflammatory myopathy.
- Understanding the long-term outcomes and associated conditions in IBM is critical for patient management.
Purpose of the Study:
- To evaluate survival rates and the prevalence of comorbidities in patients with inclusion body myositis (IBM).
- To compare these outcomes against other inflammatory myopathies (IIM) and population controls.
Main Methods:
- A population-based, case-control study utilizing the Rochester Epidemiology Project medical records-linkage system.
- Identification of 50 IBM patients, 65 IIM controls, and 294 population controls across 27 counties in Minnesota and Wisconsin.
- Comparison of comorbidity frequencies and survival rates among the identified groups.
Main Results:
- IBM patients exhibited a 10-year survival rate of 36%, significantly lower than IIM (67%) and population controls (59%).
- Higher frequencies of peripheral neuropathy (2.7x), Sjögren's syndrome (6.2x), and hematologic malignancies (3.9x) were observed in IBM patients compared to population controls.
- Dysphagia was common in IBM (64%), and respiratory failure/pneumonia was the leading cause of death (44%).
Conclusions:
- Inclusion body myositis is associated with reduced survival and an increased risk of specific comorbidities, including peripheral neuropathy, Sjögren's syndrome, and hematologic malignancies.
- These findings underscore the need for vigilant monitoring of IBM patients for potential complications to improve management and outcomes.
Related Concept Videos
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:21Myocarditis I: Introduction
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:22Myocarditis IV: Nursing Management
01:27Myocarditis II: Clinical Features and Diagnostic Tests